FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/066955 [Registered on: 07/05/2024] Trial Registered Prospectively
Last Modified On: 02/05/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Biological 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effectiveness of Platelet Rich Plasma (PRP) Injection versus Steroid injection for Knee pain in patients with Rheumatoid Arthritis (RA) – A Single blind Randomized control Trial 
Scientific Title of Study   Efficacy of Local Intra-articular Platelet Rich Plasma (PRP) Injection versus Steroids for Knee Rheumatoid Arthritis (RA) – A Single blind Randomized control Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Bismaya Sahoo 
Designation  Assistant Professor 
Affiliation  All India Institute of Medical Sciences Kalyani 
Address  Department of Orthopaedics All India Institute of Medical Sciences Kalyani
Saguna Basantapur Nadia West Bengal
Nadia
WEST BENGAL
741245
India 
Phone  9147062857  
Fax    
Email  bismaya.aiims@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Bismaya Sahoo 
Designation  Assistant Professor 
Affiliation  All India Institute of Medical Sciences Kalyani 
Address  Department of Orthopaedics All India Institute of Medical Sciences Kalyani
Saguna Basantapur Nadia West Bengal
Nadia
WEST BENGAL
741245
India 
Phone  9147062857  
Fax    
Email  bismaya.aiims@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Bismaya Sahoo 
Designation  Assistant Professor 
Affiliation  All India Institute of Medical Sciences Kalyani 
Address  Department of Orthopaedics All India Institute of Medical Sciences Kalyani
Saguna Basantapur Nadia West Bengal
Nadia
WEST BENGAL
741245
India 
Phone  9147062857  
Fax    
Email  bismaya.aiims@gmail.com  
 
Source of Monetary or Material Support  
All India Institute of Medical Sciences Kalyani, Saguna, Basantapur, Kalyani, Nadia, West Bengal, India PIN- 741245 
 
Primary Sponsor  
Name  All India Institute of Medical Sciences Kalyani 
Address  Saguna, Basantapur, Kalyani, Nadia, West Bengal, India Pin- 741245 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Bismaya Sahoo  All India Institute of Medical Sciences Kalyani  4th floor , OPD BUIlding, Department of Orthopaedics, Room no. 3, Saguna, Basantapur, Kalyani, Nadia, West Bengal, India Pin- 741245
Nadia
WEST BENGAL 
9147062857

bismaya.ortho@aiimskalyani.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, All India Institute of Medical Sciences, Kalyani  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M059||Rheumatoid arthritis with rheumatoid factor, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Local Intra-articular Platelet Rich Plasma (PRP) Injection for Knee Rheumatoid Arthritis (RA)  Patients will be randomly divided into two subgroups. In group 1, the patients will receive 3 doses of intrarticular PRP inj of 5ml each in the affected knee. Under complete aseptic condition, 1 month apart. PRP will be prepared from the autologous venous blood by using centrifuge. All patients will be assessed at baseline, 3 months and 6 month 
Comparator Agent  Local Intra-articular Injection of Steroids for Knee Rheumatoid Arthritis (RA)  In group 2, the patients will receive a single dose of local Intra-articular inj. Triamcinolone 40mg mixed with 3ml of 2% Lignocaine, in affected Knee joint. All patients will be assessed at baseline, 3 months and 6 months 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. All patients aged ≥18 years who are fulfilling 2010 ACR-EULAR classification criteria for RA.
2. Patients having low disease activity as per DAS28 criteria.
3. Patients treated with DMARD for at least 3 months with stable conditions.
4. Patients who will give consent for inclusion in the study.
 
 
ExclusionCriteria 
Details  Trauma history, local abscess, septic arthritis, patients on opioids analgesics, malignancy, pregnancy, HCV, HBV infected patients, blood disorders (coagulopathy, thrombocytopenia), and patients with previous intra-articular injection of steroid or PRP (within past 6 months). 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
VAS Score, HAQ-DI Score, Swelling score, tenderness score, and USG finding  baseline, 3 months and 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
Demographic data and disease severity  baseline, 3 months and 6 months 
 
Target Sample Size   Total Sample Size="52"
Sample Size from India="52" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   10/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Title: Efficacy of Local Intra-articular Platelet Rich Plasma (PRP) Injection versus Steroids for Knee Rheumatoid Arthritis (RA) – A Single blind Randomized control Trial.

Background: Rheumatoid Arthritis (RA) in the knee is a debilitating manifestation of systemic autoimmune disease, causing inflammation, pain, and functional impairment. This study aims to compare the effectiveness of local intra-articular Platelet Rich Plasma (PRP) injections and steroids in managing knee RA-related inflammation, pain, and quality of life.

Objective: To evaluate and compare the outcomes of local intra-articular PRP injection and intra-articular steroids in terms of pain alleviation, reduction in joint inflammation, disease activity, and improvement in quality of life in patients with knee RA.

Methodology:

Study Design: This will be a single-blind randomized controlled trial.

Study Setting: The study will take place in the Outpatient Department (OPD) of the Department of Orthopaedics at AIIMS Kalyani.

Participants: Patients aged ≥18 years fulfilling the 2010 ACR-EULAR classification criteria for RA and having low disease activity will be included.

Sample Size: The calculated sample size is 26 participants in each group, considering a 20% dropout rate.

Intervention Groups:

Group 1 (PRP): Participants will receive three doses of local intra-articular PRP injection of 5ml each prepared from autologous venous blood, administered one month apart.

Group 2 (Steroids): Participants will receive a single dose of intra-articular triamcinolone 40mg mixed with 3ml of 2 percent Lignocaine.

Outcome Measures: Participants will be assessed at baseline, 3 months, and 6 months after intervention. Outcome measures include:

Visual Analog Scale (VAS) for pain assessment.

Health Assessment Questionnaire-Disability Index (HAQ-DI) for functional status.

Swelling score and tenderness score for joint inflammation.

Ultrasound findings for joint assessment.

Data Analysis: Data will be entered into Microsoft Excel and analyzed using SPSS v25.0 and Dxt v1.0 software. Continuous variables will be expressed as means with standard deviations, and categorical data will be presented as proportions. Statistical significance will be set at P < 0.05. Intention-to-treat analysis will be performed, and additional statistical tests will be carried out if necessary.

Significance: This study addresses the need for effective local management of knee RA symptoms, focusing on pain reduction and inflammation control. By comparing PRP injections and steroids, we aim to contribute insights into improved therapeutic options for enhancing the quality of life and well-being of individuals with knee RA.

Conclusion: By conducting a rigorous randomized controlled trial, we hope to shed light on the potential benefits of local intra-articular PRP injection as an innovative therapeutic approach for knee RA. The findings could influence clinical practice and offer patients a more effective and well-tolerated treatment option.

 
Close